TY - JOUR
T1 - Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future
AU - Imamura, Masafumi
AU - Hirata, Koichi
AU - Unno, Michiaki
AU - Kamiya, Kinj
AU - Gotoh, Mitsukazu
AU - Konno, Hiroyuki
AU - Shibata, Akiko
AU - Sugihara, Kenichi
AU - Takahashi, Arata
AU - Nishiyama, Masahiko
AU - Hakamada, Kenichi
AU - Fukui, Tsuguya
AU - Furukawa, Toshiharu
AU - Mizushima, Tsunekazu
AU - Mizuma, Masamichi
AU - Miyata, Hiroaki
AU - Mori, Masaki
AU - Takemasa, Ichiro
AU - Mizuguchi, Toru
AU - Fujiwara, Toshiyoshi
N1 - Funding Information:
This project was made possible by the following Health and Labor Sciences Research Grant: “Promotion of large-scale cohort studies based on organ cancer registration in cooperation with national cancer registration and study of construction of an National Clinical Database long-term prognostic input system for a high-quality medical database” (Principal Investigator: Koichi Hirata, 2015–2017: H27-003). We are grateful to all the respondents who belong to academic societies developing cancer-related clinical practice guidelines. The 28 societies that responded to our questionnaire were The Research Group for Rare Neoplasms of Japan, Japanese Society for Cancer of the Colon and Rectum, Japanese Gastric Cancer Association, The Japan Society of Hepatology, Japanese Society of Hepato-Biliary-Pancreatic Surgery, Japan Society of Clinical Oncology: Proper management using Antiemetic agent, Japan Society of Clinical Oncology: Proper management using G-CSF, Japanese Society for Palliative Medicine, Japanese Society of Hematology, Japanese Society of Oral Oncology, Japanese Society of Thyroid Surgery, The Japanese Society of Pediatric Hematology Oncology, The Japan Esophageal Society, Japan Neuroendocrine Tumor Society, Japan Pancreas Society, The Japanese Orthopedic Association, Japan Society for Head and Neck Cancer, Japanese Breast Cancer Society, Japan Association of Breast Cancer Screening, The Japan Society for Neuro-Oncology, The Japan Lung Cancer Society, The Japanese Urological Association, Japanese Skin Cancer Society, Japan Society of Gynecologic Oncology, Japanese Society for Radiation Oncology, The Japanese Association of Rehabilitation Medicine, Japanese Society of Medical Oncology, and The Japanese Lymphedema Society.
Publisher Copyright:
© 2018, The Author(s).
PY - 2019/2/15
Y1 - 2019/2/15
N2 - Background: The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines. Methods: A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare. Results: Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary. Conclusion: In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.
AB - Background: The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines. Methods: A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare. Results: Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary. Conclusion: In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.
KW - Cancers
KW - Clinical practice guidelines
KW - Japan Society of Clinical Oncology
KW - Plan-do-check-act cycle
UR - http://www.scopus.com/inward/record.url?scp=85052327931&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052327931&partnerID=8YFLogxK
U2 - 10.1007/s10147-018-1340-1
DO - 10.1007/s10147-018-1340-1
M3 - Article
C2 - 30143906
AN - SCOPUS:85052327931
SN - 1341-9625
VL - 24
SP - 189
EP - 195
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 2
ER -
